NCT06561880
- Conditions
- AML, FLT3 Gene Mutation
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
FLT3 Gene Mutation
Explore clinical trials studying FLT3 Gene Mutation. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
FLT3 Gene Mutation trial results
Not Yet Recruiting
Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
NCT06667973
- Conditions
- Acute Myeloid Leukemia, Adult AML, Diagnosis, +11 more
- Locations
-
Not specified
Completed
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT01253070
- Conditions
- Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +12 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- AdventHealth Orlando Orlando, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
NCT04062266
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States